{"meta":{"query_hash":"20b49a8bc553","filters":{"venue":"The Women s Oncology Review"},"cohort_total":3,"direct_labels_cover":0,"predictions_cover":3,"exported":3,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/20b49a8bc553","api":"https://metacan.xera.ac/api/v1/cohort?venue=The+Women+s+Oncology+Review"},"results":[{"id":"W1995028358","doi":"10.1080/14733400500136467","title":"Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial","year":2005,"lang":"en","type":"article","venue":"The Women s Oncology Review","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Radiation therapy; Randomized controlled trial; Breast cancer; Oncology; Chemotherapy; Internal medicine; Adjuvant chemotherapy; Adjuvant; Adjuvant radiotherapy; Cancer","score_opus":0.00537213899906246,"score_gpt":0.2413558783577223,"score_spread":0.23598373935865982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995028358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9191396,0.06078459,0.00051959296,0.0059039164,0.0011222095,0.0009627067,0.0028949075,0.00011921883,0.008553143],"genre_scores_gemma":[0.9668433,0.018328264,0.00058290473,0.0035191157,0.00045417453,0.0005130203,0.0018617773,0.00004150421,0.007855924],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998938,0.00067474524,0.000046681947,0.000111420544,0.00009880618,0.00013034198],"domain_scores_gemma":[0.998195,0.0007478968,0.00037227478,0.00013082438,0.00021361557,0.00034042695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020549803,0.0007970132,0.0029432126,0.00028530322,0.0005086125,0.0010342505,0.00084783,0.0014353592,0.0045534503],"category_scores_gemma":[0.0035535828,0.0004042384,0.0017124809,0.0008076968,0.0006832334,0.00043113247,0.0003261785,0.0025049127,0.0005979044],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9272104,0.0012034862,0.007579432,0.0026720122,0.005354332,0.00012928082,0.00010429608,0.00077711063,0.001665178,0.00019697787,0.008232563,0.044875022],"study_design_scores_gemma":[0.9156315,0.014783059,0.048321173,0.0006625917,0.014319381,0.000097233555,0.00013947018,0.0007929087,0.00041339968,0.00035739283,0.0044172043,0.000064734646],"about_ca_topic_score_codex":0.0934541,"about_ca_topic_score_gemma":0.22158849,"teacher_disagreement_score":0.9065459,"about_ca_system_score_codex":0.0024704034,"about_ca_system_score_gemma":0.0033899813,"threshold_uncertainty_score":0.18582028},"labels":[],"label_agreement":null},{"id":"W3153436911","doi":"","title":"Screening and primary and secondary interventions for patients at high risk for ovarian cancer","year":2003,"lang":"en","type":"article","venue":"The Women s Oncology Review","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Ovarian cancer; Psychological intervention; Medicine; Oncology; Primary (astronomy); Internal medicine; Cancer; Gynecology; Psychiatry; Physics","score_opus":0.03752347636300222,"score_gpt":0.34950585824070896,"score_spread":0.3119823818777067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3153436911","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028620379,0.9923901,0.000037276357,0.0022722965,0.00058806577,0.000014601042,0.00001958572,0.0000034951415,0.0018125512],"genre_scores_gemma":[0.03224969,0.96267265,0.00024106355,0.0025515337,0.0011686352,0.000053891963,0.00006206169,0.0000023963944,0.0009979779],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99918216,0.00040675187,0.000093726165,0.00006351393,0.00017564591,0.00007813643],"domain_scores_gemma":[0.9979633,0.001494641,0.0002015518,0.000023230648,0.00015467829,0.00016267755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011302711,0.00035640088,0.0014493646,0.0012261752,0.00037026603,0.00059313327,0.0005474245,0.0014849692,0.005128121],"category_scores_gemma":[0.0055078818,0.00020381373,0.000996088,0.0012536311,0.0003093772,0.0006291191,0.00035731198,0.0012380535,0.00025568492],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010957832,0.00023939299,0.007321632,0.024863075,0.0004767031,0.00074922334,0.00027758392,0.00016939087,0.0002924278,0.00087031076,0.034896675,0.9287478],"study_design_scores_gemma":[0.0018056018,0.004675966,0.23148663,0.08035787,0.006596195,0.019633424,0.0021951015,0.00039134527,0.00095330813,0.003024825,0.648758,0.000121736106],"about_ca_topic_score_codex":0.004224228,"about_ca_topic_score_gemma":0.01842898,"teacher_disagreement_score":0.005128121,"about_ca_system_score_codex":0.0008926356,"about_ca_system_score_gemma":0.0023714325,"threshold_uncertainty_score":0.01715523},"labels":[],"label_agreement":null},{"id":"W4243125367","doi":"10.3109/14733400410001728456","title":"Phase III study of N, N-Diethyl-2-[4-(Phenylmethyl) Phenoxyl] Ethanamine (BMS-2173801-01) combined with doxorubicin versus doxorubicin alone in metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA-19","year":2004,"lang":"en","type":"article","venue":"The Women s Oncology Review","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Doxorubicin; Breast cancer; Medicine; Metastatic breast cancer; Cancer; Internal medicine; Oncology; Chemotherapy","score_opus":0.1757692435539034,"score_gpt":0.5063471901154966,"score_spread":0.3305779465615932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243125367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8176389,0.14261666,0.001334399,0.006948743,0.001298209,0.0069968337,0.005402108,0.000253131,0.017511036],"genre_scores_gemma":[0.8808652,0.07789951,0.0036470804,0.006952432,0.00086764735,0.0047055045,0.0049562487,0.00007432753,0.020032028],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996692,0.0001869759,0.000014164238,0.00003946066,0.000042006293,0.000048200152],"domain_scores_gemma":[0.999419,0.0001175451,0.00013783286,0.000023638651,0.00006672705,0.00023526077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013092278,0.00090112607,0.002064128,0.0003081955,0.00044390935,0.00067998254,0.0010282206,0.0015317795,0.004123483],"category_scores_gemma":[0.0010732281,0.00043083276,0.0010212351,0.00047770859,0.00051850925,0.00043832525,0.00023478163,0.0019505565,0.00070995826],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6803095,0.025737243,0.004184774,0.0035653005,0.004207522,0.00029423914,0.00028068814,0.0011986846,0.03196641,0.00066261034,0.033697177,0.21389596],"study_design_scores_gemma":[0.6733353,0.27804968,0.015001182,0.00033196114,0.002709587,0.0004298339,0.00014233206,0.00062867446,0.0040861717,0.0003250627,0.024917576,0.000042518266],"about_ca_topic_score_codex":0.013972583,"about_ca_topic_score_gemma":0.0520656,"teacher_disagreement_score":0.013972583,"about_ca_system_score_codex":0.0016349863,"about_ca_system_score_gemma":0.0036748215,"threshold_uncertainty_score":0.0277825},"labels":[],"label_agreement":null}]}